Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Common Stock (NQ:NTRB)

8.740 -1.170 (-11.81%)
Streaming Delayed Price Updated: 3:27 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nutriband Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
Via ACCESSWIRE
Nutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales 0f $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm
Via ACCESSWIRE
Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications
Via Get News
Topics Intellectual Property
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
Via ACCESSWIRE
Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023
Via ACCESSWIRE
Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador
Via ACCESSWIRE
Nutriband Unveils Groundbreaking Innovation in Transdermal Medications
ORLANDO, FL / September 20, 2023 (PlatoData via 500NewsWire) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance... 
Via TheNewswire.com
Topics Intellectual Property
Nutriband Unveils Groundbreaking Innovation in Transdermal Medications
--News Direct-- 
Via News Direct
Topics Intellectual Property
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
Patent issuance expands U.S. patent portfolio for AVERSA™ transdermal abuse deterrent technology Orlando, FL – September 20, 2023 – Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of... 
Via FinancialNewsMedia
Topics Intellectual Property
Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
Via ACCESSWIRE
Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission
Via ACCESSWIRE
Nutriband Inc. (NASDAQ: NTRB) Near the Top of Equities by Percentage Gain on 5/31
Via Investor Brand Network
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death Intellectual Property
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
Via Get News
Topics Artificial Intelligence
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
ORLANDO, FL / PlatoData via 500NewsWire / July 27, 2023 / Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced the launch of... 
Via TheNewswire.com
Topics Artificial Intelligence
Nutriband Earnings Perspective: Return On Capital Employed
Via Benzinga
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
Via ACCESSWIRE
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
--News Direct-- 
Via News Direct
Topics Artificial Intelligence
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology
Via ACCESSWIRE
Nutriband to Attend 2023 BIO International Convention
Via ACCESSWIRE
Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023
Via ACCESSWIRE
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.